FAQ Header

Which production standards and pharmacopoeias does this schisandra berry oil comply with?

Schisandra berry oil is manufactured against a comprehensive national and international standard framework — including a dedicated product national standard issued in 2025.

Standards & Pharmacopoeias

Standard / PharmacopoeiaScopeKey requirement
GB/T 43256-2025《五味子油》Direct product national standardMinimum limits for schisandrin, schisandrin B and other core actives; quality, test methods, inspection rules
Chinese Pharmacopoeia 2025 Vol. I — Schisandrae Chinensis FructusCrude drugSchisandrin ≥ 0.40% (HPLC, C18, methanol-water 65:35, 250 nm); impurities ≤ 1%, moisture ≤ 16.0%, total ash ≤ 7.0%
GB/T 26516-2011Essential oils — packaging & storagePackaging/storage general requirements
GB/T 14457.1-2008 / GB/T 14454.2-2008Refractive index / density testTest methods
GB 2762 / GB 2763Contaminant & pesticide MRL limitsHeavy metals / pesticide residues
T/CNHFA 111.X-2023Health-food raw material Wu Wei ZiFood-supplement raw material quality
T/CACM 1021.X-2023Dao-di medicinal material Bei Wu Wei ZiGeo-authenticity (Jilin Changbai)
ISO 4720:2018 / ISO 210:1999 / ISO 11024-1/2:2020Nomenclature / packaging / GC analysisInternational trade reference
Korea Pharmacopoeia (KP) / Russian PharmacopoeiaMonograph & useSchisandrae Fructus recognized
  • GB/T 43256-2025 is the FIRST national standard dedicated directly to schisandra oil — our production line is aligned with its minimum active limits
  • Dual fingerprinting (GC-MS for fatty acids + HPLC for lignans) is applied to every batch
  • The oil is produced under ISO 22000 / HACCP-aligned food-grade management where applicable

Relate Products

This article was published on 2026-09-07, and last updated on 2026-09-07. The article will be continuously updated.